<DOC>
	<DOC>NCT02078856</DOC>
	<brief_summary>The purpose of this trial is to determine the efficacy and safety of A3384 administered to patients with Bile Acid Malabsorption (BAM)/Bile Acid Diarrhoea (BAD).</brief_summary>
	<brief_title>Double-blind, Randomised Study of A3384 in BAM/BAD</brief_title>
	<detailed_description />
	<mesh_term>Malabsorption Syndromes</mesh_term>
	<criteria>Patient meets protocol specified criteria for Bile Acid Malabsorption/Bile Acid Diarrhoea Patient has successfully completed study requirements with no clinically relevant findings for physical exam, ECG, laboratory tests as applicable Medical history or medical condition that would not make the patient a good candidate for the study or limit the patientÂ´s ability to complete the study Patient needs medications prohibited as specified in the protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>